Each VIAL contains:
Quinupramine Sulphate 1.5 gm
Quinupramine Chloride 1.0 gm
Each VIAL contains:
Quinupramine Sulphate 1.5 gm
Quinupramine Chloride 1.0 gm
Curative treatment of active Trypanosomiasis (e.g., Surra, Nagana).
Control of acute clinical signs like fever, emaciation, and severe anemia.
Used for disease management in animals showing high parasitemia.
Effective against susceptible strains of Trypanosoma parasites.
Aids in the restoration of physiological function post-infection.
The active ingredient, Quinupramine, is a potent trypanocidal drug that accumulates inside the Trypanosoma parasite. Its primary mechanism is to interfere with the parasite's vital energy metabolism and interrupt key biosynthetic pathways. By disrupting these cellular processes, the drug prevents the pathogen from utilizing nutrients and replicating, leading to rapid cellular damage and death. The combination of two different salts is intended to optimize the pharmacokinetics, achieving quick therapeutic levels and providing comprehensive action against circulating parasites.
Enhanced efficacy due to the synergistic combination of two Quinupramine salts.
Rapid reduction of parasite load, halting disease progression immediately.
Convenient pre-weighed vial for accurate reconstitution and large-animal dosing.
Supports recovery by rapidly clearing the parasitic cause of anemia.
Reliable tool for managing critical cases in trypanosomiasis-endemic areas.
Cattle (Curative): Typically 1.5 - 2.5 mg/kg body weight
Deep Intramuscular (I.M.) injection.
Dissolve powder in sterile water as per package instructions to achieve recommended concentration.
Follow precise volume guidelines on the packaging for accurate dosing.
Vial (containing 2.5 gm total active ingredients)
Injection
Asia
America
Middle East
Africa
Anz
south America
EU
India